TY - JOUR
T1 - Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines
AU - Kimura, Osamu
AU - Takahashi, Takeshi
AU - Ishii, Naoto
AU - Inoue, Yuki
AU - Ueno, Yoshiyuki
AU - Kogure, Takayuki
AU - Fukushima, Koji
AU - Shiina, Masaaki
AU - Yamagiwa, Yoko
AU - Kondo, Yasuteru
AU - Inoue, Jun
AU - Kakazu, Eiji
AU - Iwasaki, Takao
AU - Kawagishi, Naoki
AU - Shimosegawa, Tooru
AU - Sugamura, Kazuo
PY - 2010/10
Y1 - 2010/10
N2 - Accumulating evidence suggests that cancer stem cells (CSC) play an important role in tumorigenicity. Epithelial cell adhesion molecule (EpCAM) is one of the markers that identifies tumor cells with high tumorigenicity. The expression of EpCAM in liver progenitor cells prompted us to investigate whether CSC could be identified in hepatocellular carcinoma (HCC) cell lines. The sorted EpCAM+ subpopulation from HCC cell lines showed a greater colony formation rate than the sorted EpCAM- subpopulation from the same cell lines, although cell proliferation was comparable between the two subpopulations. The in vivo evaluation of tumorigenicity, using supra-immunodeficient NOD/scid/γcnull (NOG) mice, revealed that a smaller number of EpCAM+ cells (minimum 100) than EpCAM- cells was necessary for tumor formation. The bifurcated differentiation of EpCAM+ cell clones into both EpCAM+ and EpCAM- cells was obvious both in vitro and in vivo, but EpCAM- clones sustained their phenotype. These clonal analyses suggested that EpCAM+ cells may contain a multipotent cell population. Interestingly, the introduction of exogenous EpCAM into EpCAM+ clones, but not into EpCAM- clones, markedly enhanced their tumor-forming ability, even though both transfectants expressed a similar level of EpCAM. Therefore, the difference in the tumor-forming ability between EpCAM+ and EpCAM- cells is probably due to the intrinsic biological differences between them. Collectively, our results suggest that the EpCAM+ population is biologically quite different from the EpCAM- population in HCC cell lines, and preferentially contains a highly tumorigenic cell population with the characteristics of CSC.
AB - Accumulating evidence suggests that cancer stem cells (CSC) play an important role in tumorigenicity. Epithelial cell adhesion molecule (EpCAM) is one of the markers that identifies tumor cells with high tumorigenicity. The expression of EpCAM in liver progenitor cells prompted us to investigate whether CSC could be identified in hepatocellular carcinoma (HCC) cell lines. The sorted EpCAM+ subpopulation from HCC cell lines showed a greater colony formation rate than the sorted EpCAM- subpopulation from the same cell lines, although cell proliferation was comparable between the two subpopulations. The in vivo evaluation of tumorigenicity, using supra-immunodeficient NOD/scid/γcnull (NOG) mice, revealed that a smaller number of EpCAM+ cells (minimum 100) than EpCAM- cells was necessary for tumor formation. The bifurcated differentiation of EpCAM+ cell clones into both EpCAM+ and EpCAM- cells was obvious both in vitro and in vivo, but EpCAM- clones sustained their phenotype. These clonal analyses suggested that EpCAM+ cells may contain a multipotent cell population. Interestingly, the introduction of exogenous EpCAM into EpCAM+ clones, but not into EpCAM- clones, markedly enhanced their tumor-forming ability, even though both transfectants expressed a similar level of EpCAM. Therefore, the difference in the tumor-forming ability between EpCAM+ and EpCAM- cells is probably due to the intrinsic biological differences between them. Collectively, our results suggest that the EpCAM+ population is biologically quite different from the EpCAM- population in HCC cell lines, and preferentially contains a highly tumorigenic cell population with the characteristics of CSC.
UR - http://www.scopus.com/inward/record.url?scp=77957051282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957051282&partnerID=8YFLogxK
U2 - 10.1111/j.1349-7006.2010.01661.x
DO - 10.1111/j.1349-7006.2010.01661.x
M3 - Article
C2 - 20707805
AN - SCOPUS:77957051282
VL - 101
SP - 2145
EP - 2155
JO - Cancer Science
JF - Cancer Science
SN - 1347-9032
IS - 10
ER -